Rebetron (Schering-Plough)
Rebetron (Schering-Plough) Brand names, Rebetron (Schering-Plough) Analogs
Rebetron (Schering-Plough) Brand Names Mixture
- No information avaliable
Rebetron (Schering-Plough) Chemical_Formula
C860H1353N229O255S9
Rebetron (Schering-Plough) RX_link
http://www.rxlist.com/cgi/generic2/ribav.htm
Rebetron (Schering-Plough) fda sheet
Rebetron (Schering-Plough) msds (material safety sheet)
Rebetron (Schering-Plough) Synthesis Reference
No information avaliable
Rebetron (Schering-Plough) Molecular Weight
19269.1
Rebetron (Schering-Plough) Melting Point
No information avaliable
Rebetron (Schering-Plough) H2O Solubility
No information avaliable
Rebetron (Schering-Plough) State
No information avaliable
Rebetron (Schering-Plough) LogP
-0.339
Rebetron (Schering-Plough) Dosage Forms
Capsule; Powder for solution; Solution (injection)
Rebetron (Schering-Plough) Indication
For treatment of Hepatitis C
Rebetron (Schering-Plough) Pharmacology
Upregulates the expression of MHC I proteins, allowing for increased presentation of peptides derived from viral antigens. This enhances the activation of CD8+ T cells that are the precursors for cytotoxic T lymphocytes (CTLs) and makes the macrophage a better target for CTL-mediated killing. Interferon alpha also induce the synthesis of several key antiviral mediators, including 2'-5' oligoadenylate synthetase (2'-5' A synthetase) and protein kinase R.
Rebetron (Schering-Plough) Absorption
No information avaliable
Rebetron (Schering-Plough) side effects and Toxicity
No information avaliable
Rebetron (Schering-Plough) Patient Information
BIOD00015.html
Rebetron (Schering-Plough) Organisms Affected
Humans and other mammals
